Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN111116510B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111116510B discloses a mild cobalt-catalyzed route for dihydrobenzothiazole derivatives, offering high yields and cost reduction in pharmaceutical intermediate manufacturing.